Relapsing-remitting Multiple Sclerosis
📧 Sign up to get email alerts when something new happens for Relapsing-remitting Multiple Sclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-03-28Clinical Trial Update: A Study of Allogeneic Hematopoietic Cell Transplantation for Primary Progressive Multiple Sclerosis [Phase 1]
This update describes a Phase 1 study evaluating allogeneic hematopoietic cell transplantation for primary progressive multiple sclerosis, w…
-
CLINICAL_TRIALS trial_result · 2025-03-27Clinical Trial Update: A Study of Multiple Sclerosis Routine Clinical Practice: Impact on Adherence and Clinical Outcomes of Ofatumumab Treated Patients
Completed clinical-trial update examining real-world adherence to and outcomes of patients with relapsing-remitting multiple sclerosis treat…
-
CLINICAL_TRIALS trial_result · 2025-03-19Clinical Trial Update: Dietary Approaches to Treat Multiple Sclerosis-Related Fatigue Study [NA]
A clinical trial evaluating dietary approaches to treat fatigue in multiple sclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2025-03-06Clinical Trial Update: Observational Study of Persistence on Bafiertam Treatment in Routine Clinical Practice
An observational study assessing persistence on Bafiertam (dimethyl fumarate) in relapsing-remitting multiple sclerosis has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-03-05Clinical Trial Update: PET with [18F]Flumazenil As an Index of Neurodegeneration in MS [NA]
The document notes completion of a clinical trial evaluating PET imaging with the radiotracer [18F]Flumazenil as an index of neurodegenerati…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-02-27Clinical Trial Update: Melatonin in Patients With Multiple Sclerosis (MS). [EARLY_Phase 1]
An early-phase study evaluating melatonin in relapsing-remitting multiple sclerosis has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2025-02-17Clinical Trial Update: Effects of Ocrelizumab on B-cell Tolerance Defect in Relapsing Multiple Sclerosis [Phase 4]
Phase 4 trial results assess the effects of ocrelizumab on B-cell tolerance defects in relapsing-remitting multiple sclerosis.
-
CLINICAL_TRIALS research · 2025-02-14Clinical Trial Update: Serum Neurofilament Light in Multiple Sclerosis
This entry notes an ongoing study of serum neurofilament light in multiple sclerosis, currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2025-02-06Clinical Trial Update: The Effect of Metformin As an Adjuvant Therapy on Immunological Parameters in Egyptian Patients with RRMS: a Pilot Study [Phase 2]
A Phase 2 pilot trial evaluated metformin as an adjuvant therapy in relapsing-remitting multiple sclerosis patients in Egypt, focusing on im…
-
EMA approval · 2025-02-05EMA Authorised: Vumerity (Diroximel fumarate (BIIB098)) — Biogen Netherlands B.V.
EMA authorised Vumerity (diroximel fumarate) for relapsing-remitting multiple sclerosis, adding a new disease-modifying therapy to Biogen's …
-
CLINICAL_TRIALS trial_result · 2025-01-22Clinical Trial Update: Safety Study to Evaluate Immune Response of Vaccines in Participants With Relapsing Forms of Multiple Sclerosis Who Receive Ozanimod Compared to Non-Pegylated Interferon (IFN)-β or No Disease Modifying Therapy [Phase 3]
A Phase 3 safety study evaluating immune responses to vaccines in relapsing forms of multiple sclerosis in participants receiving ozanimod v…
-
CLINICAL_TRIALS trial_result · 2025-01-15Clinical Trial Update: Study to Evaluate the Effectiveness and Safety of Ocrelizumab in Participants With Early Stage Relapsing Remitting Multiple Sclerosis (RRMS) [Phase 3]
This Phase 3 study evaluates the effectiveness and safety of ocrelizumab in people with early-stage relapsing-remitting multiple sclerosis; …
-
CLINICAL_TRIALS trial_result · 2025-01-07Clinical Trial Update: the Effect of Reiki Application on Depression, Anxiety and Physical Activity in Patient With Multiple Sclerosis [NA]
A completed clinical trial evaluated Reiki therapy for depression, anxiety, and physical activity in Relapsing-remitting multiple sclerosis.
-
CLINICAL_TRIALS withdrawal · 2025-01-03Clinical Trial Update: Disease Modifying Therapies Withdrawal in Inactive Relapsing-remitting Multiple Sclerosis Patients Aged 55 and Over (TWINS : Therapies Withdrawal IN Relapsing Multiple Sclerosis) [Phase 3]
This is a Phase 3 clinical trial (TWINS) evaluating withdrawal of disease-modifying therapies in inactive Relapsing-remitting Multiple Scler…
-
CLINICAL_TRIALS research · 2024-12-20Clinical Trial Update: Multiple Sclerosis and the Effects of Ketogenic Diet Therapy [NA]
A clinical trial is evaluating ketogenic diet therapy for people with relapsing-remitting multiple sclerosis; the study is currently recruit…
-
CLINICAL_TRIALS trial_result · 2024-12-18Clinical Trial Update: Effectiveness of Cladribine Tablets in Participants With Highly-active Relapsing Multiple Sclerosis (CAMELOT-MS)
A clinical trial update reports the effectiveness of cladribine tablets in participants with highly-active relapsing multiple sclerosis (CAM…
-
CLINICAL_TRIALS trial_result · 2024-12-03Clinical Trial Update: Safety, Tolerability and Efficacy of Monthly Long-acting IM Injection of 80 or 40 mg GA Depot in Subjects With RRMS [Phase 1, Phase 2]
This trial update reports on the safety, tolerability, and preliminary efficacy of monthly long-acting glatiramer acetate depot injections (…
-
CLINICAL_TRIALS trial_result · 2024-11-08Clinical Trial Update: A Study of Ocrelizumab in Children and Adolescents With Relapsing-Remitting Multiple Sclerosis [Phase 2]
This clinical trial update reports results from a Phase 2 study of ocrelizumab in children and adolescents with relapsing-remitting multiple…
-
CLINICAL_TRIALS other · 2024-10-29Clinical Trial Update: Rituximab and Ocrelizumab in Serum With Multiple Sclerosis
A clinical trial update indicates that a study evaluating serum levels of Rituximab and Ocrelizumab in Relapsing-remitting multiple sclerosi…
-
CLINICAL_TRIALS trial_result · 2024-10-28Clinical Trial Update: Upper Extremity Function in Multiple Sclerosis Patients With Advanced Disability Treated With Ocrevus
A completed clinical trial evaluating upper-extremity function in advanced multiple sclerosis patients treated with ocrelizumab (Ocrevus) an…
-
CLINICAL_TRIALS research · 2024-10-09Clinical Trial Update: Deuterium Metabolic Imaging in People with Multiple Sclerosis
A clinical trial update indicates a study on deuterium metabolic imaging in people with relapsing-remitting multiple sclerosis is currently …
-
CLINICAL_TRIALS trial_result · 2024-10-01Clinical Trial Update: Clinical Study to Investigate the Long-term Safety, Tolerability, and Efficacy of Ponesimod in Patients With Relapsing-remitting Multiple Sclerosis [Phase 2]
A Phase 2 clinical study evaluating the long-term safety, tolerability, and efficacy of ponesimod in relapsing-remitting multiple sclerosis …
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Evaluating the Efficacy and Safety of Transitioning Patients From Natalizumab to Ocrelizumab
Clinical trial evaluating the safety and efficacy of switching relapsing-remitting multiple sclerosis patients from natalizumab to ocrelizum…
-
CLINICAL_TRIALS trial_result · 2024-08-23Clinical Trial Update: Safety and Effectiveness of Generic Fingolimod (Sphingomod®, Hikma) in Patients With Relapsing-Remitting Multiple Sclerosis in Egypt
A completed clinical trial evaluated the safety and effectiveness of the generic fingolimod brand Sphingomod in patients with relapsing-remi…
-
CLINICAL_TRIALS research · 2024-08-20Clinical Trial Update: Calorie Restriction in Multiple Sclerosis [NA]
A clinical trial is investigating caloric restriction as a potential intervention for Relapsing-Remitting Multiple Sclerosis, with status li…